Compounding Pharmacies Market Size By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements), By Product (Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, Otic), By Application (Pae

Compounding Pharmacies Market Size By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements), By Product (Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, Otic), By Application (Paediatric, Adult, Geriatric, Veterinary), By Compounding Type (Pharmaceutical Ingredient Alteration [PIA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Dosage Alteration [PDA]), By Sterility (Sterile, Non-sterile), By Distribution Channel (Hospital Pharmacy, Compounding Pharmacy) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

Compounding Pharmacies market will reach USD 12.5 billion by 2024; as per a new research report.

Rising prevalence of chronic and non-communicable diseases worldwide will drive compounding pharmacy market growth over the forecast timeframe. Growing elderly population suffering from chronic diseases such as diabetes, asthma and other cardiac disorders coupled with increasing life expectancy across the world will propel the industry growth. Furthermore, increasing aesthetic concerns will fuel the demand for anti-ageing products such as testosterone therapy for men, bioidentical hormone replacement therapy for women and other high quality dermatological products that are produced in compounding pharmacies.

Dearth of cancer drugs or other essential drugs in developed region such as Europe and North America will augment the demand for compounding pharmacies over the forthcoming years. Limited supply of raw materials, production delay by manufacturers and discontinuation of commercialized drug has led to drug shortage. Ability of compounding pharmacies to fill a gap by replicating commercial drugs in case of shortage will fuel the demand for compounded medicines thereby propelling industry growth.

However, the continuous changing regulatory norms and standards will impede the market growth to some extent. Furthermore, high cost of equipment, sterility maintenance and lack of skilled lab technicians and pharmacists will hamper the growth of compounding pharmacies market.

Topical segment will show significant growth over the forecast period owing to the rising prevalence of diabetes worldwide. Growing adoption of unhealthy dietary habits and rising prevalence of obesity are the key factors increasing prevalence of diabetes among the people that subsequently lead to increase in demand of compounded long acting and rapid acting insulin analogs. Moreover, availability of other compounded topical preparations of antidiabetic drugs such as DPP-4 inhibitors and GLP-1 agonists will further witness a significant growth in the future owing to its application in treatment of type II diabetes.

Pediatric segment is estimated to grow at a considerable rate over forecast period owing to growing awareness pertaining to compounding pharmacies and increasing infant morbidity and mortality. Furthermore, customization of medicines to formulate convenient dosage forms for children such as conversion of big, solid pills into easy-to-administer liquid dosage form, will significantly boost the segment growth during analysis period.

Hormone replacement segment will grow at a faster rate during the forecast period due to increasing demand for various anti-ageing products as well hormone replacement theories among adults. Increasing focus of people on excellent quality dermatological products that are compounded as per the patients needs and requirements will further escalate hormone replacement segment growth.

U.S. compounding pharmacies market dominated the industry owing to the presence of geriatric patient pool, developed healthcare facilities and technological advancements. U.S. pharmaceutical industry has witnessed several incidences of drug shortage over the past few years. Increasing drug shortage will certainly boost demand for compounded medications.

Some of the notable industry players are Fagron, B. Braun, Fresenius Kabi, Cantrell Drug Company, McGuff, PharMEDium, Institutional Pharmacy Solutions, Triangle Compounding Pharmacies, Village Compounding Pharmacy, Pencol Compounding Pharmacy and Wedgewood Village Pharmacy. Major industry players are emphasizing on enhancing and strengthening the product portfolio. They are further focusing on partnerships and collaborations to enhance their existing systems.


Chapter 1. Methodology
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Market definition and forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
Chapter 2. Executive Summary
2.1. Compounding pharmacies industry 360 degree synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Therapeutic area trends
2.1.5. Distribution channel trends
2.1.6. Sterility type trends
2.1.7. Regional trends
Chapter 3. Compounding Pharmacies Industry Insights
3.1. Industry segmentation
3.2. Industry size and forecast, 2014 – 2025
3.3. Industry ecosystem analysis
3.3.1. Vendor matrix
3.3.2. Distribution channel analysis
3.4. Industry impact forces
3.4.1. Growth drivers
3.4.1.1. Increasing geriatric population & longevity globally
3.4.1.2. Growing acceptance of personalized medicines worldwide in U.S. and Europe
3.4.1.3. Increasing drug shortage in North America and Europe
3.4.1.4. Convenience of using compounded drugs
3.4.1.5. Growing drug failure rate
3.4.2. Industry pitfalls & challenges
3.4.2.1. Lack of skilled lab technicians and pharmacists in developed countries
3.4.2.2. High costs of equipment and maintenance of sterile environment
3.4.2.3. Changing regulatory specifications
3.4.2.4. Consumers perception towards compounded drugs
3.5. Growth potential analysis
3.5.1. By product
3.5.2. By application
3.5.3. By therapeutic area
3.5.4. By sterility
3.5.5. By distribution channel
3.6. Regulatory landscape
3.6.1. U.S
3.6.2. Europe
3.6.3. Australia
3.7. Reimbursement landscape
3.7.1. U.S.
3.7.2. Europe
3.7.3. Australia
3.8. Cost analysis of compounded medications
3.9. Compounding pharmacies count, by region 2018
3.9.1. North America
3.9.2. Europe
3.9.3. Asia Pacific
3.9.4. Latin America
3.9.5. Middle East and Africa
3.10. Innovative compounding technologies
3.10.1. Web-based quality management system
3.10.2. Digital tools
3.11. Prescriber insights
3.12. Porter’s analysis
3.13. Competitive landscape, 2018
3.13.1. Business overview
3.13.2. Strategy dashboard
3.14. PESTEL analysis
Chapter 4. Compounding Pharmacies Market, By Product
4.1. Compounding pharmacies market share, by product, 2018 & 2025
4.2. Oral
4.2.1. Market size, by region, 2014 – 2025
4.2.2. Solid preparations
4.2.2.1. Market size, by region, 2014 – 2025
4.2.2.2. Tablets
4.2.2.2.1. Market size, by region, 2014 – 2025
4.2.2.3. Capsules
4.2.2.3.1. Market size, by region, 2014 – 2025
4.2.2.4. Granules
4.2.2.4.1. Market size, by region, 2014 – 2025
4.2.2.5. Powder
4.2.2.5.1. Market size, by region, 2014 – 2025
4.2.2.6. Others
4.2.2.6.1. Market size, by region, 2014 – 2025
4.2.3. Liquid preparations
4.2.3.1. Market size, by region, 2014 – 2025
4.2.3.2. Solutions
4.2.3.2.1. Market size, by region, 2014 – 2025
4.2.3.3. Suspension
4.2.3.3.1. Market size, by region, 2014 – 2025
4.2.3.4. Emulsion
4.2.3.4.1. Market size, by region, 2014 – 2025
4.2.3.5. Syrup
4.2.3.5.1. Market size, by region, 2014 – 2025
4.2.3.6. Others
4.2.3.6.1. Market size, by region, 2014 – 2025
4.3. Topical
4.3.1. Market size, by region, 2014 – 2025
4.3.2. Ointments
4.3.2.1. Market size, by region, 2014 – 2025
4.3.3. Creams
4.3.3.1. Market size, by region, 2014 – 2025
4.3.4. Gels
4.3.4.1. Market size, by region, 2014 – 2025
4.3.5. Pastes
4.3.5.1. Market size, by region, 2014 – 2025
4.3.6. Others
4.3.6.1. Market size, by region, 2014 – 2025
4.4. Rectal
4.4.1. Market size, by region, 2014 – 2025
4.4.2. Suppositories
4.4.2.1. Market size, by region, 2014 – 2025
4.4.3. Enema
4.4.3.1. Market size, by region, 2014 – 2025
4.4.4. Others
4.4.4.1. Market size, by region, 2014 – 2025
4.5. Parenteral
4.5.1. Market size, by region, 2014 - 2025
4.6. Inhaler
4.6.1. Market size, by region, 2014 - 2025
4.7. Ophthalmic
4.7.1. Market size, by region, 2014 – 2025
4.7.1.1. Eye drops
4.7.1.1.1. Market size, by region, 2014 – 2025
4.7.1.2. Ear drops
4.7.1.2.1. Market size, by region, 2014 – 2025
4.7.1.3. Nasal drops
4.7.1.3.1. Market size, by region, 2014 – 2025
4.7.1.4. Others
4.7.1.4.1. Market size, by region, 2014 – 2025
Chapter 5. Compounding Pharmacies Market, By Application
5.1. Compounding Pharmacies market share, by application, 2018 & 2025
5.2. Pediatrics
5.2.1. Market size, by region, 2014 - 2025
5.3. Adult
5.3.1. Market size, by region, 2014 - 2025
5.4. Geriatric
5.4.1. Market size, by region, 2014 - 2025
5.5. Veterinary
5.5.1. Market size, by region, 2014 - 2025
Chapter 6. Compounding Pharmacies Market, By Therapeutic Area
6.1. Compounding pharmacies market share, by therapeutic area, 2018 & 2025
6.2. Hormone Replacement
6.2.1. Market size, by region, 2014 - 2025
6.3. Pain Management
6.3.1. Market size, by region, 2014 – 2025
6.4. Dermatology
6.4.1. Market size, by region, 2014 – 2025
6.5. Specialty drugs
6.5.1. Market size, by region, 2014 – 2025
6.6. Nutritional supplements
6.6.1. Market size, by region, 2014 – 2025
6.7. Others
6.7.1. Market size, by region, 2014 – 2025
Chapter 7. Compounding Pharmacies Market, By Sterility
7.1. Compounding pharmacies market share, by sterility, 2018 & 2025
7.2. Sterile
7.2.1. Market size, by region, 2014 - 2025
7.3. Non-sterile
7.3.1. Market size, by region, 2014 – 2025
Chapter 8. Compounding Pharmacies Market, By Distribution Channel
8.1. Compounding pharmacies market share, by distribution channel, 2018 & 2025
8.2. Hospital pharmacies
8.2.1. Market size, by region, 2014 - 2025
8.3. Compounding pharmacies
8.3.1. Market size, by region, 2014 – 2025
8.4. Others
8.4.1. Market size, by region, 2014 - 2025
Chapter 9. Compounding Pharmacies Market, By Region
9.1. Compounding pharmacies Market share, by region, 2018 & 2025
9.2. North America
9.2.1. Market size, by country, 2014 - 2025
9.2.2. Market size, by product, 2014 – 2025
9.2.2.1. Market size, by oral, 2014 - 2025
9.2.2.1.1. Market size, by solid preparations, 2014 - 2025
9.2.2.1.2. Market size, by liquid preparations, 2014 - 2025
9.2.2.2. Market size, by topical, 2014 - 2025
9.2.2.3. Market size, by rectal, 2014 - 2025
9.2.2.4. Market size, by parenteral, 2014 - 2025
9.2.3. Market size, by application, 2014 – 2025
9.2.4. Market size, by therapeutic area, 2014 – 2025
9.2.5. Market size, by sterility, 2014 – 2025
9.2.6. Market size, by distribution channel, 2014 – 2025
Similar information is provided for
9.2.7. U.S.
9.2.8. Canada
9.3. Europe
9.3.1. Market size, by country, 2014 - 2025
9.3.2. Market size, by product, 2014 – 2025
9.3.2.1. Market size, by oral, 2014 - 2025
9.3.2.1.1. Market size, by solid preparations, 2014 - 2025
9.3.2.1.2. Market size, by liquid preparations, 2014 - 2025
9.3.2.2. Market size, by topical, 2014 - 2025
9.3.2.3. Market size, by rectal, 2014 - 2025
9.3.3. Market size, by parenteral, 2014 – 2025
Similar information is provided for
9.3.4. Germany
9.3.5. UK
9.3.6. Italy
9.3.7. Spain
9.3.8. France
9.3.9. Poland
9.3.10. Ukraine
9.3.11. Greece
9.3.12. Sweden
9.3.13. Norway
9.3.14. Belgium
9.3.15. Czech Republic
9.3.16. Finland
9.3.17. Russia
9.4. Asia Pacific
9.4.1. Market size, by country, 2014 - 2025
9.4.2. Market size, by product, 2014 – 2025
9.4.2.1. Market size, by oral, 2014 - 2025
9.4.2.1.1. Market size, by solid preparations, 2014 - 2025
9.4.2.1.2. Market size, by liquid preparations, 2014 - 2025
9.4.2.2. Market size, by topical, 2014 - 2025
9.4.2.3. Market size, by rectal, 2014 - 2025
9.4.3. Market size, by parenteral, 2014 - 2025
9.4.4. China
9.4.4.1. Market size, by product, 2014 – 2025
9.4.4.1.1. Market size, by oral, 2014 – 2025
9.4.4.1.1.1. Market size, by solid preparations, 2014 – 2025
9.4.4.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.4.4.1.2. Market size, by topical, 2014 – 2025
9.4.4.1.3. Market size, by rectal, 2014 – 2025
9.4.4.1.4. Market size, by parenteral, 2014 – 2025
9.4.4.2. Market size, by application, 2014 – 2025
9.4.4.3. Market size, by therapeutic area, 2014 – 2025
9.4.4.4. Market size, by sterility, 2014 – 2025
9.4.4.5. Market size, by distribution channel, 2014 – 2025
9.4.5. India
9.4.5.1. Market size, by product, 2014 – 2025
9.4.5.1.1. Market size, by oral, 2014 – 2025
9.4.5.1.1.1. Market size, by solid preparations, 2014 – 2025
9.4.5.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.4.5.1.2. Market size, by topical, 2014 – 2025
9.4.5.1.3. Market size, by rectal, 2014 – 2025
9.4.5.1.4. Market size, by parenteral, 2014 – 2025
9.4.5.2. Market size, by application, 2014 – 2025
9.4.5.3. Market size, by therapeutic area, 2014 – 2025
9.4.5.4. Market size, by sterility, 2014 – 2025
9.4.5.5. Market size, by distribution channel, 2014 – 2025
9.4.6. Japan
9.4.6.1. Market size, by product, 2014 – 2025
9.4.6.1.1. Market size, by oral, 2014 – 2025
9.4.6.1.1.1. Market size, by solid preparations, 2014 – 2025
9.4.6.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.4.6.1.2. Market size, by topical, 2014 – 2025
9.4.6.1.3. Market size, by rectal, 2014 – 2025
9.4.6.1.4. Market size, by parenteral, 2014 – 2025
9.4.6.2. Market size, by application, 2014 – 2025
9.4.6.3. Market size, by therapeutic area, 2014 – 2025
9.4.6.4. Market size, by sterility, 2014 – 2025
9.4.6.5. Market size, by distribution channel, 2014 – 2025
9.4.7. Singapore
9.4.7.1. Market size, by product, 2014 – 2025
9.4.7.1.1. Market size, by oral, 2014 – 2025
9.4.7.1.1.1. Market size, by solid preparations, 2014 – 2025
9.4.7.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.4.7.1.2. Market size, by topical, 2014 – 2025
9.4.7.1.3. Market size, by rectal, 2014 – 2025
9.4.7.1.4. Market size, by parenteral, 2014 – 2025
9.4.7.2. Market size, by application, 2014 – 2025
9.4.7.3. Market size, by therapeutic area, 2014 – 2025
9.4.7.4. Market size, by sterility, 2014 – 2025
9.4.7.5. Market size, by distribution channel, 2014 – 2025
9.4.8. Australia
9.4.8.1. Market size, by product, 2014 – 2025
9.4.8.1.1. Market size, by oral, 2014 – 2025
9.4.8.1.1.1. Market size, by solid preparations, 2014 – 2025
9.4.8.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.4.8.1.2. Market size, by topical, 2014 – 2025
9.4.8.1.3. Market size, by rectal, 2014 – 2025
9.4.8.1.4. Market size, by parenteral, 2014 – 2025
9.4.8.2. Market size, by application, 2014 – 2025
9.4.8.3. Market size, by therapeutic area, 2014 – 2025
9.4.8.4. Market size, by sterility, 2014 – 2025
9.4.8.5. Market size, by distribution channel, 2014 – 2025
9.5. Latin America
9.5.1. Market size, by country, 2014 - 2025
9.5.2. Market size, by product, 2014 – 2025
9.5.2.1. Market size, by oral, 2014 - 2025
9.5.2.1.1. Market size, by solid preparations, 2014 - 2025
9.5.2.1.2. Market size, by liquid preparations, 2014 - 2025
9.5.2.2. Market size, by topical, 2014 - 2025
9.5.2.3. Market size, by rectal, 2014 - 2025
9.5.3. Market size, by parenteral, 2014 - 2025
9.5.4. Argentina
9.5.4.1. Market size, by product, 2014 – 2025
9.5.4.1.1. Market size, by oral, 2014 – 2025
9.5.4.1.1.1. Market size, by solid preparations, 2014 – 2025
9.5.4.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.5.4.1.2. Market size, by topical, 2014 – 2025
9.5.4.1.3. Market size, by rectal, 2014 – 2025
9.5.4.1.4. Market size, by parenteral, 2014 – 2025
9.5.4.2. Market size, by application, 2014 – 2025
9.5.4.3. Market size, by therapeutic area, 2014 – 2025
9.5.4.4. Market size, by sterility, 2014 – 2025
9.5.4.5. Market size, by distribution channel, 2014 – 2025
9.5.5. Brazil
9.5.5.1. Market size, by product, 2014 – 2025
9.5.5.1.1. Market size, by oral, 2014 – 2025
9.5.5.1.1.1. Market size, by solid preparations, 2014 – 2025
9.5.5.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.5.5.1.2. Market size, by topical, 2014 – 2025
9.5.5.1.3. Market size, by rectal, 2014 – 2025
9.5.5.1.4. Market size, by parenteral, 2014 – 2025
9.5.5.2. Market size, by application, 2014 – 2025
9.5.5.3. Market size, by therapeutic area, 2014 – 2025
9.5.5.4. Market size, by sterility, 2014 – 2025
9.5.5.5. Market size, by distribution channel, 2014 – 2025
9.5.6. Mexico
9.5.6.1. Market size, by product, 2014 – 2025
9.5.6.1.1. size, by Market size, by oral, 2014 – 2025
9.5.6.1.1.1. Market solid preparations, 2014 – 2025
9.5.6.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.5.6.1.2. Market size, by topical, 2014 – 2025
9.5.6.1.3. Market size, by rectal, 2014 – 2025
9.5.6.1.4. Market size, by parenteral, 2014 – 2025
9.5.6.2. Market size, by application, 2014 – 2025
9.5.6.3. Market size, by therapeutic area, 2014 – 2025
9.5.6.4. Market size, by sterility, 2014 – 2025
9.5.6.5. Market size, by distribution channel, 2014 – 2025
9.6. Middle East & Africa
9.6.1. Market size, by country, 2014 - 2025
9.6.2. Market size, by product, 2014 – 2025
9.6.2.1. Market size, by oral, 2014 - 2025
9.6.2.1.1. Market size, by solid preparations, 2014 - 2025
9.6.2.1.2. Market size, by liquid preparations, 2014 - 2025
9.6.2.2. Market size, by topical, 2014 - 2025
9.6.2.3. Market size, by rectal, 2014 - 2025
9.6.3. Market size, by parenteral, 2014 - 2025
9.6.4. South Africa
9.6.4.1. Market size, by product, 2014 – 2025
9.6.4.1.1. Market size, by oral, 2014 – 2025
9.6.4.1.1.1. Market size, by solid preparations, 2014 – 2025
9.6.4.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.6.4.1.2. Market size, by topical, 2014 – 2025
9.6.4.1.3. Market size, by rectal, 2014 – 2025
9.6.4.1.4. Market size, by parenteral, 2014 – 2025
9.6.4.2. Market size, by application, 2014 – 2025
9.6.4.3. Market size, by therapeutic area, 2014 – 2025
9.6.4.4. Market size, by sterility, 2014 – 2025
9.6.4.5. Market size, by distribution channel, 2014 – 2025
9.6.5. UAE
9.6.5.1. Market size, by product, 2014 – 2025
9.6.5.1.1. Market size, by oral, 2014 – 2025
9.6.5.1.1.1. Market size, by solid preparations, 2014 – 2025
9.6.5.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.6.5.1.2. Market size, by topical, 2014 – 2025
9.6.5.1.3. Market size, by rectal, 2014 – 2025
9.6.5.1.4. Market size, by parenteral, 2014 – 2025
9.6.5.2. Market size, by application, 2014 – 2025
9.6.5.3. Market size, by therapeutic area, 2014 – 2025
9.6.5.4. Market size, by sterility, 2014 – 2025
9.6.5.5. Market size, by distribution channel, 2014 – 2025
9.6.6. Saudi Arabia
9.6.6.1. Market size, by product, 2014 – 2025
9.6.6.1.1. Market size, by oral, 2014 – 2025
9.6.6.1.1.1. Market size, by solid preparations, 2014 – 2025
9.6.6.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.6.6.1.2. Market size, by topical, 2014 – 2025
9.6.6.1.3. Market size, by rectal, 2014 – 2025
9.6.6.1.4. Market size, by parenteral, 2014 – 2025
9.6.6.2. Market size, by application, 2014 – 2025
9.6.6.3. Market size, by therapeutic area, 2014 – 2025
9.6.6.4. Market size, by sterility, 2014 – 2025
9.6.6.5. Market size, by distribution channel, 2014 – 2025
9.6.7. Qatar
9.6.7.1. Market size, by product, 2014 – 2025
9.6.7.1.1. Market size, by oral, 2014 – 2025
9.6.7.1.1.1. Market size, by solid preparations, 2014 – 2025
9.6.7.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.6.7.1.2. Market size, by topical, 2014 – 2025
9.6.7.1.3. Market size, by rectal, 2014 – 2025
9.6.7.1.4. Market size, by parenteral, 2014 – 2025
9.6.7.2. Market size, by application, 2014 – 2025
9.6.7.3. Market size, by therapeutic area, 2014 – 2025
9.6.7.4. Market size, by sterility, 2014 – 2025
9.6.7.5. Market size, by distribution channel, 2014 – 2025
9.6.8. Kuwait
9.6.8.1. Market size, by product, 2014 – 2025
9.6.8.1.1. Market size, by oral, 2014 – 2025
9.6.8.1.1.1. Market size, by solid preparations, 2014 – 2025
9.6.8.1.1.2. Market size, by liquid preparations, 2014 – 2025
9.6.8.1.2. Market size, by topical, 2014 – 2025
9.6.8.1.3. Market size, by rectal, 2014 – 2025
9.6.8.1.4. Market size, by parenteral, 2014 – 2025
9.6.8.2. Market size, by application, 2014 – 2025
9.6.8.3. Market size, by therapeutic area, 2014 – 2025
9.6.8.4. Market size, by sterility, 2014 – 2025
9.6.8.5. Market size, by distribution channel, 2014 – 2025
Chapter 10. Company Profiles
10.1. B. Braun Medical
10.1.1. Business overview
10.1.2. Financial data
10.1.3. Product landscape
10.1.4. Strategic outlook
10.1.5. SWOT analysis
10.2. Doughtery’s Pharmacy
10.2.1. Business overview
10.2.2. Financial data
10.2.3. Product landscape
10.2.4. Strategic outlook
10.2.5. SWOT analysis
10.3. Fagron
10.3.1. Business overview
10.3.2. Financial data
10.3.3. Product landscape
10.3.4. Strategic outlook
10.3.5. SWOT analysis
10.4. Fresenuis Kabi
10.4.1. Business overview
10.4.2. Financial data
10.4.3. Product landscape
10.4.4. Strategic outlook
10.4.5. SWOT analysis
10.5. Institutional Pharmacy solutions
10.5.1. Business overview
10.5.2. Financial data
10.5.3. Product landscape
10.5.4. Strategic outlook
10.5.5. SWOT analysis
10.6. ITC Compounding Pharmacy
10.6.1. Business overview
10.6.2. Financial data
10.6.3. Product landscape
10.6.4. Strategic outlook
10.6.5. SWOT analysis
10.7. Lorraine’s Pharmacy
10.7.1. Business overview
10.7.2. Financial data
10.7.3. Product landscape
10.7.4. Strategic outlook
10.7.5. SWOT analysis
10.8. Mcguff compounding pharmacy services
10.8.1. Business overview
10.8.2. Financial data
10.8.3. Product landscape
10.8.4. Strategic outlook
10.8.5. SWOT analysis
10.9. Pencol Compounding Pharmacy
10.9.1. Business overview
10.9.2. Financial data
10.9.3. Product landscape
10.9.4. Strategic outlook
10.9.5. SWOT analysis
10.10. PharmMEDium
10.10.1. Business overview
10.10.2. Financial data
10.10.3. Product landscape
10.10.4. Strategic outlook
10.10.5. SWOT analysis
10.11. Rx3 Compounding Pharmacy
10.11.1. Business overview
10.11.2. Financial data
10.11.3. Product landscape
10.11.4. Strategic outlook
10.11.5. SWOT analysis
10.12. Triangle compounding Pharmacies
10.12.1. Business overview
10.12.2. Financial data
10.12.3. Product landscape
10.12.4. Strategic outlook
10.12.5. SWOT analysis
10.13. Village compounding Pharmacies
10.13.1. Business overview
10.13.2. Financial data
10.13.3. Product landscape
10.13.4. Strategic outlook
10.13.5. SWOT analysis
10.14. Wedgewood Village Pharmacy
10.14.1. Business overview
10.14.2. Financial data
10.14.3. Product landscape
10.14.4. Strategic outlook
10.14.5. SWOT analysis
Data Tables
TABLE 1. Compounding pharmacies industry 360 degree synopsis, 2014 – 2025
TABLE 2. Compounding pharmacies market, 2014 – 2025 (USD Million)
TABLE 3. Compounding pharmacies market, by product, 2014 – 2025 (USD Million)
TABLE 4. Compounding pharmacies market, by product, 2014 – 2025 (USD Million)
TABLE 5. Compounding pharmacies market, by application, 2014 – 2025 (USD Million)
TABLE 6. Compounding pharmacies market, by therapeutic area, 2014 – 2025 (USD Million)
TABLE 7. Compounding pharmacies market, by sterility, 2014 – 2025 (USD Million)
TABLE 8. Compounding pharmacies market, by distribution channel, 2014 – 2025 (USD Million)
TABLE 9. Compounding pharmacies market, by region, 2014 – 2025 (USD Million)
TABLE 10. Industry impact forces
TABLE 11. Oral market by region, 2014 – 2025 (USD Million)
TABLE 12. Solid preparations market, by region, 2014 - 2025, (USD Mn)
TABLE 13. Tablets market, by region, 2014 - 2025, (USD Million)
TABLE 14. Capsules market, by region, 2014 - 2025, (USD Million)
TABLE 15. Granules market, by region, 2014 - 2025, (USD Million)
TABLE 16. Powder market, by region, 2014 - 2025, (USD Million)
TABLE 17. Others market, by region, 2014 - 2025, (USD Million)
TABLE 18. Liquid preparations market, by region, 2014 - 2025, (USD Million)
TABLE 19. Solutions market, by region, 2014 - 2025, (USD Million)
TABLE 20. Suspension market, by region, 2014 - 2025, (USD Mn)
TABLE 21. Emulsion market, by region, 2014 - 2025, (USD Million)
TABLE 22. Syrup market, by region, 2014 - 2025, (USD Million)
TABLE 23. Others market, by region, 2014 - 2025, (USD Million)
TABLE 24. Topical market, by region, 2014 - 2025, (USD Million)
TABLE 25. Ointments market, by region, 2014 - 2025, (USD Million)
TABLE 26. Creams market, by region, 2014 - 2025, (USD Million)
TABLE 27. Gels market, by region, 2014 - 2025, (USD Million)
TABLE 28. Pastes market, by region, 2014 - 2025, (USD Million)
TABLE 29. Others market, 2014 - 2025, (USD Million)
TABLE 30. Rectal market by region, 2014 – 2025 (USD Million)
TABLE 31. Suppositories market, by region, 2014 - 2025, (USD Mn)
TABLE 32. Enema market, by region, 2014 - 2025, (USD Million)
TABLE 33. Others market, by region, 2014 - 2025, (USD Million)
TABLE 34. Parenteral market by region, 2014 – 2025 (USD Million)
TABLE 35. Ophthalmic market by region, 2014 – 2025 (USD Million)
TABLE 36. Pediatric compounding pharmacies market, by region, 2014 - 2025, (USD Million)
TABLE 37. Adult compounding pharmacies market, by region 2014 - 2025, (USD Million)
TABLE 38. Geriatric compounding pharmacies market, by region 2014 - 2025, (USD Million)
TABLE 39. Veterinary compounding pharmacies market, by region 2014 - 2025, (USD Million)
TABLE 40. Hormone replacement compounding pharmacies market, by region, 2014 - 2025, (USD Mn)
TABLE 41. Sterile compounding pharmacies market, by region, 2014 - 2025, (USD Mn)
TABLE 42. Non-sterile compounding pharmacies market, by region, 2014 - 2025, (USD Mn)
TABLE 43. Hospital compounding pharmacies market, by region, 2014 - 2025, (USD Mn)
TABLE 44. Others market, by region, 2014 - 2025, (USD Mn)
TABLE 45. North America compounding pharmacies market, by country, 2014 - 2025 (USD Million)
TABLE 46. North America compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 47. North America compounding pharmacies market, by oral, 2014 - 2025 (USD Million)
TABLE 48. North America compounding pharmacies market, by solid preparations, 2014 - 2025 (USD Million)
TABLE 49. North America compounding pharmacies market, by liquid preparations, 2014 - 2025 (USD Million)
TABLE 50. North America compounding pharmacies market, by topical, 2014 - 2025 (USD Million)
TABLE 51. North America compounding pharmacies market, by rectal, 2014 - 2025 (USD Million)
TABLE 52. North America compounding pharmacies market, by parenteral, 2014 - 2025 (USD Million)
TABLE 53. North America compounding pharmacies market, by application, 2014 - 2025 (USD Mn)
TABLE 54. North America compounding pharmacies market, by therapeutic areas, 2014 - 2025 (USD Million)
TABLE 55. North America compounding pharmacies market, by sterility, 2014 - 2025 (USD Million)
TABLE 56. North America compounding pharmacies market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 57. U.S. compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 58. U.S. compounding pharmacies market, by oral, 2014 - 2025 (USD Million)
TABLE 59. U.S. compounding pharmacies market, by solid preparations, 2014 - 2025 (USD Million)
TABLE 60. U.S. compounding pharmacies market, by liquid preparations, 2014 - 2025 (USD Million)
TABLE 61. U.S. compounding pharmacies market, by topical, 2014 - 2025 (USD Million)
TABLE 62. U.S. compounding pharmacies market, by rectal, 2014 - 2025 (USD Million)
TABLE 63. U.S. compounding pharmacies market, by parenteral, 2014 - 2025 (USD Million)
TABLE 64. U.S. compounding pharmacies market, by application, 2014 - 2025 (USD Million)
TABLE 65. U.S. compounding pharmacies market, by therapeutic areas, 2014 - 2025 (USD Million)
TABLE 66. U.S. compounding pharmacies market, by sterility, 2014 - 2025 (USD Million)
TABLE 67. U.S. compounding pharmacies market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 68. Canada compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 69. Canada compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 70. Canada compounding pharmacies market, by oral, 2014 - 2025 (USD Million)
TABLE 71. Canada compounding pharmacies market, by solid preparations, 2014 - 2025 (USD Million)
TABLE 72. Canada compounding pharmacies market, by liquid preparations, 2014 - 2025 (USD Million)
TABLE 73. Canada compounding pharmacies market, by topical, 2014 - 2025 (USD Million)
TABLE 74. Canada compounding pharmacies market, by rectal, 2014 - 2025 (USD Million)
TABLE 75. Canada compounding pharmacies market, by parenteral, 2014 - 2025 (USD Million)
TABLE 76. Canada compounding pharmacies market, by application, 2014 - 2025 (USD Million)
TABLE 77. Canada compounding pharmacies market, by therapeutic areas, 2014 - 2025 (USD Million)
TABLE 78. Canada compounding pharmacies market, by sterility, 2014 - 2025 (USD Million)
TABLE 79. Canada compounding pharmacies market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 80. Europe compounding pharmacies market, by country 2014 - 2025 (USD Million)
TABLE 81. Europe compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 82. Europe compounding pharmacies market, by application, 2014 - 2025 (USD Million)
TABLE 83. Europe compounding pharmacies market, by therapeutic areas, 2014 - 2025 (USD Million)
TABLE 84. Europe compounding pharmacies market, by sterility, 2014 - 2025 (USD Million)
TABLE 85. Europe compounding pharmacies market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 86. Europe compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 87. Europe compounding pharmacies market, by oral, 2014 - 2025 (USD Million)
TABLE 88. Europe compounding pharmacies market, by solid preparations, 2014 - 2025 (USD Million)
TABLE 89. Europe compounding pharmacies market, by liquid preparations, 2014 - 2025 (USD Million)
TABLE 90. Europe compounding pharmacies market, by topical, 2014 - 2025 (USD Million)
TABLE 91. Europe compounding pharmacies market, by rectal, 2014 - 2025 (USD Million)
TABLE 92. Europe compounding pharmacies market, by parenteral, 2014 - 2025 (USD Million)
TABLE 93. Germany compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 94. Germany compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 95. Germany compounding pharmacies market, by oral, 2014 - 2025 (USD Million)
TABLE 96. Germany compounding pharmacies market, by solid preparations, 2014 - 2025 (USD Million)
TABLE 97. Germany compounding pharmacies market, by liquid preparations, 2014 - 2025 (USD Million)
TABLE 98. Germany compounding pharmacies market, by topical, 2014 - 2025 (USD Million)
TABLE 99. Germany compounding pharmacies market, by rectal, 2014 - 2025 (USD Million)
TABLE 100. Germany compounding pharmacies market, by parenteral, 2014 - 2025 (USD Million)
TABLE 101. Germany compounding pharmacies market, by application, 2014 - 2025 (USD Million)
TABLE 102. Germany compounding pharmacies market, by therapeutic areas, 2014 - 2025 (USD Million)
TABLE 103. Germany compounding pharmacies market, by sterility, 2014 - 2025 (USD Million)
TABLE 104. Germany compounding pharmacies market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 105. UK compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 106. UK compounding pharmacies market, by application, 2014 - 2025 (USD Million)
TABLE 107. UK compounding pharmacies market, by therapeutic areas, 2014 - 2025 (USD Million)
TABLE 108. UK compounding pharmacies market, by sterility, 2014 - 2025 (USD Million)
TABLE 109. UK compounding pharmacies market, by distribution channel, 2014 - 2025 (USD Million)
TABLE 110. UK compounding pharmacies market, by product, 2014 - 2025 (USD Million)
TABLE 111. UK compounding pharmacies market, by oral, 2014 - 2025 (USD Million)
TABLE 112. UK compounding pharmacies market, by solid preparations, 2014 - 2025 (USD Million)
TABLE 113. UK compounding pharmacies market, by liquid preparations, 2014 - 2025 (USD Million)
TABLE 146. France compounding pharmacies market, by application, 2014 - 2025 (USD Million)
<

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook